TLSA (Tiziana Life Sciences Ltd. Common Shares) Stock Analysis - SEC Filings

Tiziana Life Sciences Ltd. Common Shares (TLSA) is a publicly traded Healthcare sector company. As of May 19, 2026, TLSA trades at $1.38 with a market cap of $171.80M and a P/E ratio of 0.00. TLSA moved +2.96% today. Year to date, TLSA is -13.75%; over the trailing twelve months it is -6.76%. Its 52-week range spans $0.63 to $2.60. Rallies surfaces TLSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find TLSA SEC filings?

Rallies organizes TLSA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

TLSA Key Metrics

Key financial metrics for TLSA
MetricValue
Price$1.38
Market Cap$171.80M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$2.60
52-Week Low$0.63
Volume243.75K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest TLSA News

TLSA Analyst Consensus

TLSA analyst coverage data. Average price target: $0.00.

Common questions about TLSA

Where can I find TLSA SEC filings?
Rallies organizes TLSA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show TLSA 10-K and 10-Q filings?
Rallies organizes TLSA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is TLSA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TLSA. It does not provide personalized investment advice.
TLSA

TLSA